Dr Fader on Letrozole With or Without Paclitaxel and Carboplatin in Ovarian Serous Carcinoma

Amanda Nickles Fader, MD, discusses the randomized, phase 3 NRG-GY019 trial evaluating letrozole with or without paclitaxel and carboplatin in patients with stage II to IV primary low-grade serous carcinoma of the ovary or peritoneum.

Related Keywords

,Amanda Nickles Fader ,Johns Hopkins Health System ,Gynecologic Surgical Operations ,Johns Hopkins Medicine ,Cleveland Clinic ,Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins ,Gynecologic Oncology ,Onclive Tv ,